# Gemcitabine and Carboplatin for Elderly Patient With Lung Cancer

> **NCT00881296** · PHASE2 · COMPLETED · sponsor: **Hamamatsu University** · enrollment: 60 (actual)

## Conditions studied

- Non-Small Cell Lung Cancer

## Interventions

- **DRUG:** gemcitabine and carboplatin
- **DRUG:** Gemcitabine

## Key facts

- **NCT ID:** NCT00881296
- **Lead sponsor:** Hamamatsu University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-03
- **Primary completion:** 2011-03
- **Final completion:** 2011-06
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2011-09-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00881296

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00881296, "Gemcitabine and Carboplatin for Elderly Patient With Lung Cancer". Retrieved via AI Analytics 2026-07-09 from https://api.ai-analytics.org/clinical/NCT00881296. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*